Tessera Therapeutics
Biotech tool for writing precise, permanent genetic changes to treat inherited diseases
Funding
$500.00M
2022
Details
Headquarters
Cambridge, United States
Website
Milestones
FOUNDING YEAR
2018
Filings
Company documents and regulatory filings for Tessera Therapeutics.
| Name | Type | Filed At | Actions |
|---|---|---|---|
|
tessera-therapeutics_coi_2022-02-25
|
Certificate of Incorporation
|
Feb 25, 2022
|
View PDF |